Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel
- 1 March 2010
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 8 (3) , 482-488
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Cytochrome P-450 Polymorphisms and Response to ClopidogrelNew England Journal of Medicine, 2009
- Cardiovascular Death and Nonfatal Myocardial Infarction in Acute Coronary Syndrome Patients Receiving Coronary Stenting Are Predicted by Residual Platelet Reactivity to ADP Detected by a Point-of-Care AssayCirculation, 2009
- Quantitative determination of clopidogrel active metabolite in human plasma by LC–MS/MSJournal of Pharmaceutical and Biomedical Analysis, 2008
- Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrelThrombosis and Haemostasis, 2008
- Evaluation of the platelet response to clopidogrel with light transmittance aggregometry: peak aggregation or late aggregation?Journal of Thrombosis and Haemostasis, 2007
- Determination of Clopidogrel Resistance by Whole Blood Platelet Aggregometry and Inhibitors of the P2Y12 ReceptorClinical Chemistry, 2006
- Dependence of Platelet Thrombus Stability on Sustained Glycoprotein IIb/IIIa Activation Through Adenosine 5′-Diphosphate Receptor Stimulation and Cyclic Calcium SignalingJACC, 2006
- Variability in platelet responsiveness to clopidogrel among 544 individualsJACC, 2005
- Pharmacokinetics of clopidogrel after administration of a high loading doseThrombosis and Haemostasis, 2004
- Clopidogrel for Coronary StentingCirculation, 2003